nourianzhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | NOURIANZ® (istradefylline) | |
| Description | April is Parkinson’s Awareness An adenosine A2A receptor antagonist indicated as adjunctive treatment to reduce “off” time in Parkinson’s |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 168.61.217.214 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
nourianzhcp.com Valuation
|
US$6,372,451
Last updated: 2023-05-17 05:10:23
nourianzhcp.com has Semrush global rank of 1,660,947. nourianzhcp.com has an estimated worth of US$ 6,372,451, based on its estimated Ads revenue. nourianzhcp.com receives approximately 735,283 unique visitors each day. Its web server is located in United States, with IP address 168.61.217.214. According to SiteAdvisor, nourianzhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,372,451 |
| Daily Ads Revenue | US$5,883 |
| Monthly Ads Revenue | US$176,468 |
| Yearly Ads Revenue | US$2,117,615 |
| Daily Unique Visitors | 49,019 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| nourianzhcp.com. | A | 598 | IP: 168.61.217.214 |
| nourianzhcp.com. | NS | 21600 | NS Record: nsgbr.comlaude.co.uk. |
| nourianzhcp.com. | NS | 21600 | NS Record: nssui.comlaude.ch. |
| nourianzhcp.com. | NS | 21600 | NS Record: nsusa.comlaude.net. |
| nourianzhcp.com. | TXT | 600 | TXT Record: eqgp08pvigbkn3080t5m0n1gbm |
| nourianzhcp.com. | TXT | 600 | TXT Record: nourianzhcp.azurewebsites.net |
| nourianzhcp.com. | TXT | 600 | TXT Record: 59AE1DF99727EE1BE5F94E78099DC91D23E876E210873DC2EC8BEDCA33DFA4B3 |
HtmlToTextCheckTime:2023-05-17 05:10:23
| This site is for US healthcare professionals only Full Prescribing Information Important Safety Information Patient Website GET UPDATES Menu GET UPDATES Role of Adenosine in PD The NOURIANZ Difference Mechanism of Action PET Scans Efficacy Primary Endpoint - "Off" Time Secondary Endpoint - "On" Time Safety Trial Design Adverse Reactions Dosing One Pill, Once-Daily Dosing Dosage Adjustments Patient Support Co-pay Assistance Starting Patients on NOURIANZ NOURIANZ Resources Educational Presentations Downloadable Materials Add NOURIANZ ® , the only treatment for “off” time in Parkinson’s disease (PD) that lifts the brake of adenosine, 1,2 to help your patients brake for what matters to them. Role of Adenosine Efficacy Safety Resources Actor Portrayals. Role of Adenosine Efficacy Safety Resources × April is Parkinson’s Awareness Month Kyowa Kirin recognizes the courage of nearly 1 million people living with Parkinson’s disease in the United States. did you know within 5 YEARS OF STARTING |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=UTF-8 Location: https://nourianzhcp.com/ Date: Mon, 07 Mar 2022 08:47:43 GMT HTTP/1.1 301 Moved Permanently Content-Length: 185 Content-Type: text/html Location: https://www.nourianzhcp.com/ Server: nginx/1.14.2 Date: Mon, 07 Mar 2022 08:47:43 GMT HTTP/1.1 200 OK Content-Length: 0 Content-Type: text/html; charset=UTF-8 Server: nginx/1.14.2 X-Powered-By: PHP/8.0.11 Date: Mon, 07 Mar 2022 08:47:45 GMT |
nourianzhcp.com Whois Information
Domain Name: NOURIANZHCP.COM Registry Domain ID: 2366297753_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2022-02-03T23:05:10Z Creation Date: 2019-03-05T09:57:34Z Registry Expiry Date: 2023-03-05T09:57:34Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: ok https://icann.org/epp#ok Name Server: NSGBR.COMLAUDE.CO.UK Name Server: NSSUI.COMLAUDE.CH Name Server: NSUSA.COMLAUDE.NET DNSSEC: unsigned >>> Last update of whois database: 2022-03-07T09:01:48Z <<< |